Zobrazeno 1 - 10
of 30
pro vyhledávání: '"Veronica Francardo"'
Autor:
Fabio Fais, Reda Juskeviciene, Veronica Francardo, Stéphanie Mateos, Manuela Guyard, Cécile Viollet, Samuel Constant, Massimo Borelli, Ilja P. Hohenfeld
Publikováno v:
International Journal of Molecular Sciences, Vol 23, Iss 7, p 4062 (2022)
The nasal epithelium is a key portal for infection by respiratory viruses such as SARS-CoV-2 and represents an important target for prophylactic and therapeutic interventions. In the present study, we test the safety and efficacy of a newly developed
Externí odkaz:
https://doaj.org/article/c610d4d5d1f845119f340f0c1f9c7af8
Publikováno v:
Neurobiology of Disease, Vol 94, Iss , Pp 213-225 (2016)
Mice with striatal 6-hydroxydopamine (6-OHDA) lesions are widely used as a model to study the effects of neurorestorative, symptomatic, or antidyskinetic treatments for Parkinson's disease (PD). The standard praxis is to utilize young adult mice with
Externí odkaz:
https://doaj.org/article/8b73bc0a0e774c46b53a947c7c092603
Publikováno v:
Neurobiology of Disease, Vol 82, Iss , Pp 561-573 (2015)
There is increasing awareness that the medications used to treat the motor symptoms of Parkinson's disease (PD) contribute to the development of behavioral addictions, which have been clinically defined as impulsive–compulsive behaviors (ICBs). The
Externí odkaz:
https://doaj.org/article/236d9ad2524e434bb7176d1c73ec92a7
Autor:
Veronica Francardo, Alessandra Recchia, Nataljia Popovic, Daniel Andersson, Hans Nissbrandt, M. Angela Cenci
Publikováno v:
Neurobiology of Disease, Vol 42, Iss 3, Pp 327-340 (2011)
6-Hydroxydopamine (6-OHDA) lesions are being used in the mouse for basic research on Parkinson's disease and L-DOPA-induced dyskinesia. We set out to compare unilateral lesion models produced by intrastriatal or intramesencephalic injections of a fix
Externí odkaz:
https://doaj.org/article/9edac35517eb480499887d97ddd7ccf1
Autor:
Veronica Francardo, Samuel Constant, Thomas F. Meyer, Ilja P. Hohenfeld, Massimo Borelli, Fabio Fais, Reda Juskeviciene, Stéphanie Mateos
BackgroundFor SARS-CoV-2 and other respiratory viruses, the nasal epithelium is a key portal for infection. Therefore, the nose is an important target of prophylactic and therapeutic interventions against these viruses. We developed a nasal spray (AM
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::99bab543788da61f1f95a8b50f781071
https://doi.org/10.1101/2021.07.12.452021
https://doi.org/10.1101/2021.07.12.452021
Autor:
Quentin Denis, Veronica Francardo, Michal Geva, Michael R. Hayden, M. Angela Cenci, Lilach Steiner, Francesco Bez
Publikováno v:
Neurotherapeutics
Pridopidine is a small molecule in clinical development for the treatment of Huntington’s disease. It was recently found to have high binding affinity to the sigma-1 receptor, a chaperone protein involved in cellular defense mechanisms and neuropla
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::267aa441586295712f0ac8c728dcb161
https://doi.org/10.1007/s13311-018-00699-9
https://doi.org/10.1007/s13311-018-00699-9
Autor:
Marta Codrich, Rosario Gulino, Nunzio Vicario, Gioacchino de Leo, Marino Coradazzi, Rosalba Parenti, Veronica Francardo, Elena Giusto, Massimo Gulisano, Giampiero Leanza
Plastic changes have been reported in the SOD1-G93A mouse model of amyotrophic lateral sclerosis, a disorder characterized by progressive motoneuronal loss; however, whether these changes related with the onset and development of motor impairments is
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::278f83ec0ee8ac39a91afe461e3e4ef6
http://hdl.handle.net/11390/1162480
http://hdl.handle.net/11390/1162480
Publikováno v:
Neurobiology of Disease, Vol 94, Iss, Pp 213-225 (2016)
Mice with striatal 6-hydroxydopamine (6-OHDA) lesions are widely used as a model to study the effects of neurorestorative, symptomatic, or antidyskinetic treatments for Parkinson's disease (PD). The standard praxis is to utilize young adult mice with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bd41686af1af72dea768b2f04209c294
http://www.sciencedirect.com/science/article/pii/S0969996116301383
http://www.sciencedirect.com/science/article/pii/S0969996116301383
Autor:
Peter F. Morgenstern, M. Angela Cenci, Paul Greengard, Roberta Marongiu, Xiaoqun Zhang, Margarita Arango-Lievano, Per Svenningsson, Michael G. Kaplitt, Veronica Francardo
Publikováno v:
Proceedings of the National Academy of Sciences. 113:1423-1428
Complications of dopamine replacement for Parkinson's disease (PD) can limit therapeutic options, leading to interest in identifying novel pathways that can be exploited to improve treatment. p11 (S100A10) is a cellular scaffold protein that binds to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::89c84cb270e191362ca6d331cd6eb0dc
https://doi.org/10.1073/pnas.1524387113
https://doi.org/10.1073/pnas.1524387113
Autor:
Veronica Francardo, Geidy E. Serrano, Henrik Zetterberg, Elisabet Londos, Charles H. Adler, Sara Hall, M. Angela Cenci, Kaj Blennow, Danielle van Westen, Oskar Hansson, Thomas G. Beach, Daniel Lindqvist, Shorena Janelidze
Publikováno v:
Neurology
Objective: To study biomarkers of angiogenesis in Parkinson disease (PD), and how these are associated with clinical characteristics, blood–brain barrier (BBB) permeability, and cerebrovascular disease. Methods: In this cross-sectional analysis, 38
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::212f924fd4c47d5c7a011b40d7420a1b
https://doi.org/10.1212/wnl.0000000000002151
https://doi.org/10.1212/wnl.0000000000002151